W161 Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications
Lanier R, Bogenschutz M, Schindler E, Kelmendi B, Durgin C, Ashworth J. W161 Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications. Drug And Alcohol Dependence 2024, 260: 110862. DOI: 10.1016/j.drugalcdep.2023.110862.Peer-Reviewed Original ResearchEfficacy of psilocybinTherapeutic efficacyPsilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial
Schindler E, Sewell R, Gottschalk C, Flynn L, Zhu Y, Pittman B, Cozzi N, D'Souza D. Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial. Journal Of The Neurological Sciences 2024, 460: 122993. PMID: 38581739, DOI: 10.1016/j.jns.2024.122993.Peer-Reviewed Original ResearchConceptsAttack frequencyCluster headacheCluster headache attack frequencyExtension phaseEffects of repeated treatmentReduction of attack frequencyPlacebo-controlled studyHeadache attack frequencyAdministration of psilocybinRandomized controlled trialsDouble-blindPsilocybin administrationPulse regimenAdverse eventsPulse regimensHeadache diaryTherapeutic efficacyDrug sessionsPulse administrationHeadacheStudy participantsWeeks